--Roche Holding is losing money in Russia because medicine prices are set in rubles, Chief Executive Severin Schwan tells Swiss newspaper Tages-Anzeiger in an interview.
--The CEO said the company has a responsibility to the patients who are depending on its medicines, and that it has 800 workers in Russia, though no production sites, the newspaper reports.
--Roche said in a statement that about 1% of group sales are generated in Russia.
Full story in German: https://bit.ly/35j0WLx
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
03-29-22 0645ET